Literature DB >> 16299547

Study of the mechanisms involved in the vasorelaxation induced by (-)-epigallocatechin-3-gallate in rat aorta.

Ezequiel Alvarez1, Manuel Campos-Toimil, Hélène Justiniano-Basaran, Claire Lugnier, Francisco Orallo.   

Abstract

This study investigated several mechanisms involved in the vasorelaxant effects of (-)-epigallocatechin-3-gallate (EGCG). EGCG (1 microM-1 mM) concentration dependently relaxed, after a transient increase in tension, contractions induced by noradrenaline (NA, 1 microM), high extracellular KCl (60 mM), or phorbol 12-myristate 13-acetate (PMA, 1 microM) in intact rat aortic rings. In a Ca2+ -free solution, EGCG (1 microM-1 mM) relaxed 1 microM PMA-induced contractions, without previous transient contraction. However, EGCG (1 microM-1 mM) did not affect the 1 microM okadaic acid-induced contractions. Removal of endothelium and/or pretreatment with glibenclamide (10 microM), tetraethylammonium (2 mM) or charybdotoxin (100 nM) plus apamin (500 nM) did not modify the vasorelaxant effects of EGCG. In addition, EGCG noncompetitively antagonized the contractions induced by NA (in 1.5 mM Ca2+ -containing solution) and Ca2+ (in depolarizing Ca2+ -free high KCl 60 mM solution). In rat aortic smooth muscle cells (RASMC), EGCG (100 microM) reduced increases in cytosolic free Ca2+ concentration ([Ca2+]i) induced by angiotensin II (ANG II, 100 nM) and KCl (60 mM) in 1.5 mM CaCl2 -containing solution and by ANG II (100 nM) in the absence of extracellular Ca2+. In RASMC, EGCG (100 microM) did not modify basal generation of cAMP or cGMP, but significantly reversed the inhibitory effects of NA (1 microM) and high KCl (60 mM) on cAMP and cGMP production. EGCG inhibited the enzymatic activity of all the cyclic nucleotide PDE isoenzymes present in vascular tissue, being more effective on PDE2 (IC50 approximately 17) and on PDE1 (IC50 approximately 25). Our results suggest that the vasorelaxant effects of EGCG in rat aorta are mediated, at least in part, by an inhibition of PDE activity, and the subsequent increase in cyclic nucleotide levels in RASMC, which, in turn, can reduce agonist- or high KCl concentration-induced increases in [Ca2+]i.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16299547      PMCID: PMC1751301          DOI: 10.1038/sj.bjp.0706507

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  53 in total

1.  Comparative study of the vasorelaxant activity, superoxide-scavenging ability and cyclic nucleotide phosphodiesterase-inhibitory effects of hesperetin and hesperidin.

Authors:  Francisco Orallo; Ezequiel Alvarez; Hélène Basaran; Claire Lugnier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-11-17       Impact factor: 3.000

2.  Cyclic nucleotide phosphodiesterase activities from pig coronary arteries. Lack of interconvertibility of major forms.

Authors:  T M Keravis; J N Wells; J G Hardman
Journal:  Biochim Biophys Acta       Date:  1980

3.  (-)-Epigallocatechin-3-gallate induces contraction of the rat aorta by a calcium influx-dependent mechanism.

Authors:  Ezequiel Alvarez-Castro; Manuel Campos-Toimil; Francisco Orallo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-04-09       Impact factor: 3.000

4.  Comparison of green tea extract and epigallocatechin gallate on blood pressure and contractile responses of vascular smooth muscle of rats.

Authors:  Dong-Yoon Lim; Eun-Sook Lee; Hyeon-Gyoon Park; Byeong-Cheol Kim; Soon-Pyo Hong; Eun-Bang Lee
Journal:  Arch Pharm Res       Date:  2003-03       Impact factor: 4.946

5.  Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.

Authors:  Wun-Chang Ko; Chwen-Ming Shih; Ya-Hsin Lai; Jun-Hao Chen; Hui-Lin Huang
Journal:  Biochem Pharmacol       Date:  2004-11-15       Impact factor: 5.858

6.  Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice.

Authors:  Kuang-Yuh Chyu; Stephanie M Babbidge; Xiaoning Zhao; Ram Dandillaya; Anton G Rietveld; Juliana Yano; Paul Dimayuga; Bojan Cercek; Prediman K Shah
Journal:  Circulation       Date:  2004-05-10       Impact factor: 29.690

7.  Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.

Authors:  Gianfranco Fassina; Roberta Venè; Monica Morini; Simona Minghelli; Roberto Benelli; Douglas M Noonan; Adriana Albini
Journal:  Clin Cancer Res       Date:  2004-07-15       Impact factor: 12.531

8.  Modulation of Ca2+ sensitivity by cyclic nucleotides in smooth muscle from protein kinase G-deficient mice.

Authors:  Johan Bonnevier; Reinhard Fässler; Andrew P Somlyo; Avril V Somlyo; Anders Arner
Journal:  J Biol Chem       Date:  2003-11-10       Impact factor: 5.157

9.  The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells.

Authors:  Antje Ludwig; Mario Lorenz; Nicole Grimbo; Frederike Steinle; Silke Meiners; Cornelia Bartsch; Karl Stangl; Gert Baumann; Verena Stangl
Journal:  Biochem Biophys Res Commun       Date:  2004-04-09       Impact factor: 3.575

10.  A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation.

Authors:  Mario Lorenz; Silja Wessler; Elena Follmann; Wanda Michaelis; Thomas Düsterhöft; Gert Baumann; Karl Stangl; Verena Stangl
Journal:  J Biol Chem       Date:  2003-11-24       Impact factor: 5.157

View more
  19 in total

1.  Cyclic nucleotide signalling compartmentation by PDEs in cultured vascular smooth muscle cells.

Authors:  Liang Zhang; Kaouter Bouadjel; Boris Manoury; Grégoire Vandecasteele; Rodolphe Fischmeister; Véronique Leblais
Journal:  Br J Pharmacol       Date:  2019-04-24       Impact factor: 8.739

2.  (-)-epigallocatechin gallate inhibits the pacemaker activity of interstitial cells of cajal of mouse small intestine.

Authors:  Kweon Young Kim; Soo Jin Choi; Hyuk Jin Jang; Dong Chuan Zuo; Pawan Kumar Shahi; Shankar Prasad Parajuli; Cheol Ho Yeum; Pyung Jin Yoon; Seok Choi; Jae Yeoul Jun
Journal:  Korean J Physiol Pharmacol       Date:  2008-06-30       Impact factor: 2.016

3.  Endothelium/nitric oxide mechanism mediates vasorelaxation and counteracts vasoconstriction induced by low concentration of flavanols.

Authors:  Annalisa Aggio; Davide Grassi; Eugenia Onori; Antonio D'Alessandro; Francesco Masedu; Marco Valenti; Claudio Ferri
Journal:  Eur J Nutr       Date:  2012-02-10       Impact factor: 5.614

Review 4.  Green tea catechins and cardiovascular health: an update.

Authors:  Pon Velayutham Anandh Babu; Dongmin Liu
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

5.  Hydrogenosome metabolism is the key target for antiparasitic activity of resveratrol against Trichomonas vaginalis.

Authors:  Natalia Mallo; Jesús Lamas; José M Leiro
Journal:  Antimicrob Agents Chemother       Date:  2013-03-11       Impact factor: 5.191

6.  Comparison of inhibitors of superoxide generation in vascular smooth muscle cells.

Authors:  Z Luo; Y Chen; S Chen; W J Welch; B T Andresen; P A Jose; C S Wilcox
Journal:  Br J Pharmacol       Date:  2009-05-18       Impact factor: 8.739

7.  Design and synthesis of novel selective estrogen receptor degradation inducers based on the diphenylheptane skeleton.

Authors:  Takashi Misawa; Takuma Fujisato; Yasunari Kanda; Nobumichi Ohoka; Takuji Shoda; Momoko Yorioka; Makoto Makishima; Yuko Sekino; Mikihiko Naito; Yosuke Demizu; Masaaki Kurihara
Journal:  Medchemcomm       Date:  2016-12-08       Impact factor: 3.597

8.  Endothelial NO Production Is Mandatory for Epigallocatechin-3-Gallate-induced Vasodilation: Results From eNOS Knockout (eNOS-/-) Mice.

Authors:  Mario Lorenz; Laura Klinkner; Gert Baumann; Karl Stangl; Verena Stangl
Journal:  J Cardiovasc Pharmacol       Date:  2015-06       Impact factor: 3.105

9.  Delphinidin Inhibits Tumor Growth by Acting on VEGF Signalling in Endothelial Cells.

Authors:  Thérèse Keravis; Laure Favot; Abdurrazag A Abusnina; Anita Anton; Hélène Justiniano; Raffaella Soleti; Eid Alabed Alibrahim; Gilles Simard; Ramaroson Andriantsitohaina; Claire Lugnier
Journal:  PLoS One       Date:  2015-12-22       Impact factor: 3.240

10.  Cyclooxygenase-1 and prostacyclin production by endothelial cells in the presence of mild oxidative stress.

Authors:  Alice Toniolo; Carola Buccellati; Christian Pinna; Rosa Maria Gaion; Angelo Sala; Chiara Bolego
Journal:  PLoS One       Date:  2013-02-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.